Antithrombotic Regimen After Percutaneous Left Atrial Appendage Closure　― A Real-World Study ―-Reference-Cited by-同舟云学术

Antithrombotic Regimen After Percutaneous Left Atrial Appendage Closure　― A Real-World Study ―

Published:2023-11-24 Issue:12 Volume:87 Page:1820-1827
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Ryuzaki Satoko¹,Kondo Yusuke¹,Nakano Miyo¹,Nakano Masahiro²,Kajiyama Takatsugu²,Ito Ryo¹,Kitagawa Mari¹,Sugawara Masafumi¹,Chiba Toshinori¹,Yoshino Yutaka¹,Kobayashi Yoshio¹

Affiliation:

1. Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine

2. Department of Advanced Cardiorhythm Therapeutics, Chiba University Graduate School of Medicine

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/87/12/87_CJ-22-0687/_pdf

Reference27 articles.

1. 1. Pisters R, Lane DA, Nieuwlaat R, Vos CB, Crijns H, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey. Chest 2010; 138: 1093–1100.

2. 2. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium. Circulation 2011; 123: 2736–2747.

3. 3. Nogami A, Kurita T, Kusano K, Goya M, Shoda M, Tada H, et al; the Japanese Circulation Society/the Japanese Heart Rhythm Society Joint Working Group. JCS/JHRS 2021 guideline focused update on non-pharmacotherapy of cardiac arrhythmias. Circ J 2022; 86: 337–363, doi:10.1253/circj.CJ-21-0162.

4. 4. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised non-inferiority trial. Lancet 2009; 374: 534–542.

5. 5. Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, et al. Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial. J Am Coll Cardiol 2014; 64: 1–12.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticoagulation Strategies in Post-LAA Closure Ablation for Atrial Fibrillation: A Research Imperative;Cardiology in Review;2024-09-05

2. Comparative Data of Procedural and Midterm Outcomes in Patients Who Underwent Percutaneous Left Atrial Appendage Closure Between the WATCHMAN FLX and WATCHMAN 2.5 Devices　― Insight From the OCEAN-LAAC Registry ―;Circulation Journal;2024-06-25

3. Editorial to “Safety and feasibility of atrial fibrillation ablation after left atrial appendage closure: A single‐center experience of the left atrial appendage closure‐first strategy”;Journal of Arrhythmia;2024-06-18

4. Zero-Contrast Left Atrial Appendage Closure in Patients With Chronic Kidney Disease;Circulation Journal;2023-12-25

5. Mid-Term Feasibility of Percutaneous Left Atrial Appendage Occlusion in Elderly Patients with Non-Valvular Atrial Fibrillation;Journal of Clinical Medicine;2023-09-18